Literature DB >> 31391887

Binding site characterization - similarity, promiscuity, and druggability.

Christiane Ehrt1, Tobias Brinkjost1,2, Oliver Koch1.   

Abstract

The elucidation of non-obvious binding site similarities has provided useful indications for the establishment of polypharmacology, the identification of potential off-targets, or the repurposing of known drugs. The concept underlying all of these approaches is promiscuous binding which can be analyzed from a ligand-based or a binding site-based perspective. Herein, we applied methods for the automated analysis and comparison of protein binding sites to study promiscuous binding on a novel dataset of sites in complex with ligands sharing common shape and physicochemical properties. We show the suitability of this dataset for the benchmarking of novel binding site comparison methods. Our investigations also reveal promising directions for further in-depth analyses of promiscuity and druggability in a pocket-centered manner. Drawbacks concerning binding site similarity assessment and druggability prediction are outlined, enabling researchers to avoid the typical pitfalls of binding site analyses.

Year:  2019        PMID: 31391887      PMCID: PMC6644390          DOI: 10.1039/c9md00102f

Source DB:  PubMed          Journal:  Medchemcomm        ISSN: 2040-2503            Impact factor:   3.597


  66 in total

1.  A new method to detect related function among proteins independent of sequence and fold homology.

Authors:  Stefan Schmitt; Daniel Kuhn; Gerhard Klebe
Journal:  J Mol Biol       Date:  2002-10-18       Impact factor: 5.469

2.  Identification and prediction of promiscuous aggregating inhibitors among known drugs.

Authors:  James Seidler; Susan L McGovern; Thompson N Doman; Brian K Shoichet
Journal:  J Med Chem       Date:  2003-10-09       Impact factor: 7.446

3.  PISCES: a protein sequence culling server.

Authors:  Guoli Wang; Roland L Dunbrack
Journal:  Bioinformatics       Date:  2003-08-12       Impact factor: 6.937

Review 4.  The druggable genome.

Authors:  Andrew L Hopkins; Colin R Groom
Journal:  Nat Rev Drug Discov       Date:  2002-09       Impact factor: 84.694

5.  UCSF Chimera--a visualization system for exploratory research and analysis.

Authors:  Eric F Pettersen; Thomas D Goddard; Conrad C Huang; Gregory S Couch; Daniel M Greenblatt; Elaine C Meng; Thomas E Ferrin
Journal:  J Comput Chem       Date:  2004-10       Impact factor: 3.376

Review 6.  Clinically important pharmacokinetic drug-drug interactions: role of cytochrome P450 enzymes.

Authors:  E Tanaka
Journal:  J Clin Pharm Ther       Date:  1998-12       Impact factor: 2.512

7.  LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters.

Authors:  Gerhard Wolber; Thierry Langer
Journal:  J Chem Inf Model       Date:  2005 Jan-Feb       Impact factor: 4.956

8.  Druggability indices for protein targets derived from NMR-based screening data.

Authors:  Philip J Hajduk; Jeffrey R Huth; Stephen W Fesik
Journal:  J Med Chem       Date:  2005-04-07       Impact factor: 7.446

9.  Kinetic and structural basis of reactivity of pentaerythritol tetranitrate reductase with NADPH, 2-cyclohexenone, nitroesters, and nitroaromatic explosives.

Authors:  Huma Khan; Richard J Harris; Terez Barna; Daniel H Craig; Neil C Bruce; Andrew W Munro; Peter C E Moody; Nigel S Scrutton
Journal:  J Biol Chem       Date:  2002-03-28       Impact factor: 5.157

10.  Recognition of functional sites in protein structures.

Authors:  Alexandra Shulman-Peleg; Ruth Nussinov; Haim J Wolfson
Journal:  J Mol Biol       Date:  2004-06-04       Impact factor: 5.469

View more
  4 in total

1.  Editorial: Chemoinformatics Approaches to Structure- and Ligand-Based Drug Design, Volume II.

Authors:  Leonardo L G Ferreira; Adriano D Andricopulo
Journal:  Front Pharmacol       Date:  2022-06-29       Impact factor: 5.988

2.  Common Structural Pattern for Flecainide Binding in Atrial-Selective Kv1.5 and Nav1.5 Channels: A Computational Approach.

Authors:  Yuliet Mazola; José C E Márquez Montesinos; David Ramírez; Leandro Zúñiga; Niels Decher; Ursula Ravens; Vladimir Yarov-Yarovoy; Wendy González
Journal:  Pharmaceutics       Date:  2022-06-27       Impact factor: 6.525

3.  Structural analysis of mycobacterial homoserine transacetylases central to methionine biosynthesis reveals druggable active site.

Authors:  Catherine T Chaton; Emily S Rodriguez; Robert W Reed; Jian Li; Cameron W Kenner; Konstantin V Korotkov
Journal:  Sci Rep       Date:  2019-12-30       Impact factor: 4.379

4.  Unlocking COVID therapeutic targets: A structure-based rationale against SARS-CoV-2, SARS-CoV and MERS-CoV Spike.

Authors:  João Trigueiro-Louro; Vanessa Correia; Inês Figueiredo-Nunes; Marta Gíria; Helena Rebelo-de-Andrade
Journal:  Comput Struct Biotechnol J       Date:  2020-07-31       Impact factor: 7.271

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.